Skip banner and top navigation
NHLBI Logo and Link
National Heart, Lung, and Blood Institute: People, Science, Health
 TEXT SIZE: 
 HOME  SITE INDEX  CONTACT US
  
About NHLBI
Link to the National Institutes of Health Link to the Department of Health and Human Services

Division of Cardiovascular Diseases

ATHEROTHROMBOSIS & CORONARY ARTERY DISEASE BRANCH

The Atherothrombosis and Coronary Artery Disease Branch conducts and manages an integrated basic and clinical research program to study the etiology, pathogenesis, prevention, diagnosis, and treatment of CAD and atherothrombosis. It is responsible for translating promising scientific and technological advances from discovery through preclinical studies to networks and multisite clinical trials. Areas addressed by the Branch include:

  • Atherothrombosis: initiation, progression, and regression of atherosclerotic lesions in coronary arteries and other arterial beds; lesion instability and thrombosis; risk factor mechanisms; interaction of lipid fractions and other systemic and humoral factors with the arterial wall; biomarker and imaging diagnostics to quantify atherosclerotic disease and its progression; vulnerable plaques and vulnerable patients; and diabetes, obesity, other metabolic disorders, and diet and exercise related to atherothrombosis.
  • Coronary Artery Disease: acute and chronic coronary syndromes including myocardial infarction, acute ischemia and related events, angina, and silent ischemia; and percutaneous and surgical revascularization of stenotic and re-stenotic coronary lesions.

The Atherothrombosis and Coronary Artery Disease Branch, DCVD may be contacted at 301-435-0550.

September 2008

Skip footer links and go to content

HOME · SEARCH · ACCESSIBILITY · SITE INDEX · OTHER SITES · PRIVACY STATEMENT · FOIA · CONTACT US